Concept scores are derived automatically based on a person's publications. Keywords in the their attributed publications are matched to keywords from the National Library of Medicine's controlled vocabulary thesaurus, MeSH (Medical Subject Headings). The strength of a person's concept scores is based not only on the number of corresponding publications, but also how relevant the concepts are to the overall topics of the publications, how long ago the publications were written, whether the person was the first or senior author, and how many other people have written about the topic.Concepts cannot be directly edited. You can help ensure your concepts are accurate by making sure your attributed publications are correct and up-to-date. We recommend checking over your attributed publications list every three to four months.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Pulmonary Disease, Chronic Obstructive | 8 | 2023 | 146 | 3.020 |
Why?
|
| Lung Neoplasms | 13 | 2023 | 631 | 2.510 |
Why?
|
| Climate Change | 3 | 2024 | 53 | 2.100 |
Why?
|
| Cannabis | 3 | 2023 | 150 | 1.660 |
Why?
|
| Endoscopic Ultrasound-Guided Fine Needle Aspiration | 5 | 2023 | 45 | 1.650 |
Why?
|
| Respiratory Tract Diseases | 2 | 2024 | 28 | 1.520 |
Why?
|
| Air Pollution | 2 | 2024 | 49 | 1.490 |
Why?
|
| Biopsy, Fine-Needle | 5 | 2021 | 104 | 1.320 |
Why?
|
| Ticlopidine | 3 | 2016 | 72 | 1.270 |
Why?
|
| Platelet Aggregation Inhibitors | 3 | 2016 | 212 | 1.150 |
Why?
|
| Marijuana Smoking | 2 | 2023 | 75 | 1.140 |
Why?
|
| Endosonography | 4 | 2023 | 96 | 1.050 |
Why?
|
| Bronchoscopes | 3 | 2023 | 9 | 1.040 |
Why?
|
| Dyspnea | 6 | 2015 | 80 | 1.020 |
Why?
|
| Bronchoscopy | 5 | 2019 | 75 | 1.020 |
Why?
|
| Tracheostomy | 2 | 2020 | 76 | 1.010 |
Why?
|
| Lung | 6 | 2023 | 499 | 1.010 |
Why?
|
| Lymph Nodes | 3 | 2017 | 252 | 0.970 |
Why?
|
| Pleural Effusion | 4 | 2019 | 38 | 0.910 |
Why?
|
| Humans | 50 | 2024 | 52469 | 0.870 |
Why?
|
| Ultrasonography, Interventional | 2 | 2015 | 139 | 0.800 |
Why?
|
| Insufflation | 1 | 2023 | 12 | 0.790 |
Why?
|
| Auscultation | 2 | 2015 | 9 | 0.760 |
Why?
|
| Cannabinoids | 1 | 2022 | 104 | 0.690 |
Why?
|
| Oxygen | 1 | 2023 | 333 | 0.650 |
Why?
|
| Lung Injury | 1 | 2020 | 25 | 0.640 |
Why?
|
| Heart Failure | 2 | 2016 | 579 | 0.630 |
Why?
|
| Male | 31 | 2020 | 26794 | 0.630 |
Why?
|
| Smoking Cessation | 3 | 2020 | 315 | 0.610 |
Why?
|
| Pleural Diseases | 2 | 2016 | 11 | 0.600 |
Why?
|
| Pulmonary Medicine | 2 | 2015 | 14 | 0.600 |
Why?
|
| Middle Aged | 23 | 2020 | 13084 | 0.590 |
Why?
|
| Continuous Positive Airway Pressure | 1 | 2019 | 65 | 0.580 |
Why?
|
| Asthma | 3 | 2013 | 316 | 0.550 |
Why?
|
| Hemorrhage | 2 | 2016 | 224 | 0.540 |
Why?
|
| Female | 26 | 2020 | 28192 | 0.530 |
Why?
|
| Tracheal Neoplasms | 1 | 2016 | 8 | 0.510 |
Why?
|
| Granular Cell Tumor | 1 | 2016 | 6 | 0.510 |
Why?
|
| Pandemics | 1 | 2021 | 586 | 0.500 |
Why?
|
| Cytodiagnosis | 1 | 2015 | 42 | 0.480 |
Why?
|
| Mediastinal Neoplasms | 1 | 2015 | 18 | 0.470 |
Why?
|
| Respiratory Sounds | 2 | 2015 | 50 | 0.470 |
Why?
|
| Esophagus | 2 | 2016 | 83 | 0.470 |
Why?
|
| Arteriovenous Fistula | 1 | 2015 | 27 | 0.460 |
Why?
|
| Angiography | 1 | 2015 | 115 | 0.460 |
Why?
|
| Lung Diseases, Interstitial | 1 | 2015 | 26 | 0.450 |
Why?
|
| Adrenal Glands | 1 | 2014 | 39 | 0.450 |
Why?
|
| Adolescent Behavior | 1 | 2015 | 105 | 0.430 |
Why?
|
| Algorithms | 2 | 2015 | 669 | 0.420 |
Why?
|
| Retrospective Studies | 9 | 2023 | 6643 | 0.420 |
Why?
|
| Aged | 14 | 2020 | 10193 | 0.410 |
Why?
|
| Coitus | 1 | 2013 | 18 | 0.410 |
Why?
|
| Blood Loss, Surgical | 1 | 2013 | 69 | 0.410 |
Why?
|
| Lung Diseases | 1 | 2014 | 85 | 0.400 |
Why?
|
| Thoracostomy | 1 | 2012 | 10 | 0.400 |
Why?
|
| Chest Tubes | 1 | 2012 | 20 | 0.390 |
Why?
|
| Mediastinal Diseases | 1 | 2012 | 7 | 0.390 |
Why?
|
| Respiration, Artificial | 3 | 2023 | 296 | 0.380 |
Why?
|
| Preoperative Care | 1 | 2013 | 174 | 0.380 |
Why?
|
| Cricoid Cartilage | 1 | 2012 | 11 | 0.370 |
Why?
|
| Adult | 13 | 2023 | 14151 | 0.370 |
Why?
|
| Thoracic Diseases | 1 | 2011 | 9 | 0.360 |
Why?
|
| Rectal Neoplasms | 1 | 2012 | 52 | 0.360 |
Why?
|
| Carcinoma, Squamous Cell | 4 | 2019 | 330 | 0.360 |
Why?
|
| Stress, Psychological | 1 | 2013 | 273 | 0.350 |
Why?
|
| Intubation, Intratracheal | 1 | 2012 | 117 | 0.340 |
Why?
|
| Particulate Matter | 2 | 2024 | 63 | 0.340 |
Why?
|
| Kidney | 1 | 2015 | 722 | 0.330 |
Why?
|
| Lung Diseases, Obstructive | 1 | 2008 | 28 | 0.300 |
Why?
|
| Quality of Life | 3 | 2020 | 881 | 0.290 |
Why?
|
| Cough | 2 | 2017 | 56 | 0.290 |
Why?
|
| Prostheses and Implants | 2 | 2019 | 55 | 0.280 |
Why?
|
| Disease Progression | 3 | 2022 | 872 | 0.280 |
Why?
|
| Tomography, X-Ray Computed | 5 | 2017 | 1162 | 0.270 |
Why?
|
| Diagnostic Imaging | 1 | 2008 | 173 | 0.270 |
Why?
|
| Prospective Studies | 5 | 2019 | 2449 | 0.270 |
Why?
|
| Bronchial Hyperreactivity | 1 | 2007 | 5 | 0.260 |
Why?
|
| Adenocarcinoma | 3 | 2017 | 402 | 0.260 |
Why?
|
| Pilot Projects | 4 | 2020 | 719 | 0.250 |
Why?
|
| Aged, 80 and over | 5 | 2019 | 3413 | 0.250 |
Why?
|
| Chronic Disease | 2 | 2023 | 588 | 0.240 |
Why?
|
| Ozone | 1 | 2024 | 20 | 0.230 |
Why?
|
| Postoperative Complications | 1 | 2012 | 1080 | 0.220 |
Why?
|
| Air Pollutants | 1 | 2024 | 75 | 0.210 |
Why?
|
| Risk Assessment | 2 | 2020 | 1348 | 0.210 |
Why?
|
| Environmental Exposure | 1 | 2024 | 216 | 0.200 |
Why?
|
| Receptors, Cannabinoid | 1 | 2022 | 18 | 0.200 |
Why?
|
| Pleural Effusion, Malignant | 2 | 2015 | 21 | 0.190 |
Why?
|
| Smoking | 2 | 2017 | 517 | 0.190 |
Why?
|
| Ultrasonography | 2 | 2016 | 423 | 0.190 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 2 | 2016 | 168 | 0.180 |
Why?
|
| Analgesics | 1 | 2022 | 104 | 0.180 |
Why?
|
| Swine | 1 | 2023 | 427 | 0.180 |
Why?
|
| Airway Resistance | 2 | 2014 | 17 | 0.170 |
Why?
|
| Device Approval | 1 | 2020 | 3 | 0.170 |
Why?
|
| Neoplasm Staging | 3 | 2019 | 765 | 0.160 |
Why?
|
| Thoracoscopy | 2 | 2019 | 17 | 0.160 |
Why?
|
| Hemoptysis | 1 | 2019 | 4 | 0.160 |
Why?
|
| Manometry | 1 | 2019 | 22 | 0.150 |
Why?
|
| Delayed Diagnosis | 1 | 2019 | 30 | 0.150 |
Why?
|
| Exercise Therapy | 1 | 2020 | 100 | 0.150 |
Why?
|
| Pressure | 1 | 2019 | 103 | 0.150 |
Why?
|
| Adolescent | 3 | 2015 | 6708 | 0.150 |
Why?
|
| Home Care Services | 1 | 2020 | 71 | 0.150 |
Why?
|
| Small Cell Lung Carcinoma | 1 | 2019 | 30 | 0.150 |
Why?
|
| Respiratory Function Tests | 2 | 2020 | 90 | 0.150 |
Why?
|
| Time-to-Treatment | 1 | 2019 | 78 | 0.140 |
Why?
|
| Neoplasms, Muscle Tissue | 1 | 2017 | 12 | 0.140 |
Why?
|
| Aging | 1 | 2023 | 707 | 0.140 |
Why?
|
| Critical Illness | 1 | 2020 | 312 | 0.140 |
Why?
|
| Inflammation | 1 | 2022 | 643 | 0.140 |
Why?
|
| Liver Cirrhosis | 1 | 2020 | 243 | 0.130 |
Why?
|
| Predictive Value of Tests | 2 | 2021 | 944 | 0.130 |
Why?
|
| Gender Identity | 1 | 2017 | 26 | 0.130 |
Why?
|
| United States | 2 | 2020 | 5225 | 0.130 |
Why?
|
| Referral and Consultation | 1 | 2019 | 292 | 0.130 |
Why?
|
| Bronchial Fistula | 1 | 2016 | 5 | 0.130 |
Why?
|
| Mediastinum | 1 | 2016 | 21 | 0.130 |
Why?
|
| Tomography Scanners, X-Ray Computed | 1 | 2016 | 11 | 0.130 |
Why?
|
| Metabolome | 1 | 2017 | 102 | 0.130 |
Why?
|
| Prevalence | 2 | 2017 | 1016 | 0.130 |
Why?
|
| Prognosis | 3 | 2020 | 2113 | 0.130 |
Why?
|
| Prosthesis Implantation | 1 | 2016 | 49 | 0.130 |
Why?
|
| Airway Obstruction | 1 | 2016 | 49 | 0.120 |
Why?
|
| Treatment Outcome | 3 | 2016 | 5471 | 0.120 |
Why?
|
| Exercise Test | 2 | 2020 | 144 | 0.120 |
Why?
|
| Laser Therapy | 1 | 2016 | 76 | 0.120 |
Why?
|
| Gambling | 1 | 2015 | 18 | 0.120 |
Why?
|
| Air Pollution, Indoor | 1 | 2015 | 27 | 0.120 |
Why?
|
| Cost Savings | 1 | 2015 | 58 | 0.120 |
Why?
|
| Pleurodesis | 1 | 2015 | 8 | 0.120 |
Why?
|
| Pleura | 1 | 2015 | 13 | 0.120 |
Why?
|
| Epidemics | 1 | 2015 | 25 | 0.120 |
Why?
|
| Pneumothorax | 1 | 2015 | 20 | 0.120 |
Why?
|
| Environmental Monitoring | 1 | 2015 | 74 | 0.120 |
Why?
|
| Physical Exertion | 1 | 2015 | 46 | 0.120 |
Why?
|
| Tobacco Smoke Pollution | 1 | 2015 | 55 | 0.120 |
Why?
|
| Neoplasm Grading | 1 | 2015 | 125 | 0.110 |
Why?
|
| Foot | 1 | 2015 | 41 | 0.110 |
Why?
|
| Esophageal Neoplasms | 2 | 2019 | 111 | 0.110 |
Why?
|
| Comorbidity | 1 | 2017 | 631 | 0.110 |
Why?
|
| Neoplasm Invasiveness | 1 | 2015 | 277 | 0.110 |
Why?
|
| Arginine | 1 | 2016 | 181 | 0.110 |
Why?
|
| Edema | 1 | 2015 | 65 | 0.110 |
Why?
|
| Sex Factors | 1 | 2017 | 731 | 0.110 |
Why?
|
| Cost-Benefit Analysis | 1 | 2015 | 269 | 0.110 |
Why?
|
| Nitric Oxide | 1 | 2016 | 244 | 0.110 |
Why?
|
| Erythrocyte Indices | 1 | 2013 | 7 | 0.110 |
Why?
|
| Dilatation | 1 | 2013 | 27 | 0.100 |
Why?
|
| Addison Disease | 1 | 2013 | 3 | 0.100 |
Why?
|
| Hyperkalemia | 1 | 2013 | 12 | 0.100 |
Why?
|
| Hyponatremia | 1 | 2013 | 13 | 0.100 |
Why?
|
| Sensitivity and Specificity | 1 | 2015 | 883 | 0.100 |
Why?
|
| Age Factors | 1 | 2016 | 1131 | 0.100 |
Why?
|
| Opioid-Related Disorders | 1 | 2017 | 399 | 0.100 |
Why?
|
| Cardiac Catheterization | 1 | 2015 | 241 | 0.100 |
Why?
|
| Patient Safety | 1 | 2013 | 103 | 0.100 |
Why?
|
| Immunohistochemistry | 1 | 2015 | 980 | 0.100 |
Why?
|
| Case-Control Studies | 2 | 2013 | 1198 | 0.100 |
Why?
|
| Hypotension | 1 | 2013 | 62 | 0.100 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 65 | 0.090 |
Why?
|
| Analgesics, Opioid | 1 | 2017 | 590 | 0.090 |
Why?
|
| Neoplasms, Squamous Cell | 1 | 2011 | 7 | 0.090 |
Why?
|
| Pneumonia | 2 | 2017 | 125 | 0.090 |
Why?
|
| Necrosis | 1 | 2012 | 170 | 0.090 |
Why?
|
| Respiratory Insufficiency | 1 | 2012 | 117 | 0.090 |
Why?
|
| Fatigue | 1 | 2012 | 129 | 0.090 |
Why?
|
| Neoplasms | 1 | 2021 | 1302 | 0.090 |
Why?
|
| Cohort Studies | 1 | 2015 | 1550 | 0.090 |
Why?
|
| Needs Assessment | 1 | 2012 | 139 | 0.090 |
Why?
|
| Blood Gas Analysis | 1 | 2011 | 28 | 0.090 |
Why?
|
| Intensive Care Units | 1 | 2012 | 235 | 0.090 |
Why?
|
| Radiography | 1 | 2012 | 474 | 0.090 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2014 | 1372 | 0.080 |
Why?
|
| Severity of Illness Index | 2 | 2011 | 1038 | 0.080 |
Why?
|
| Follow-Up Studies | 1 | 2015 | 2288 | 0.080 |
Why?
|
| Palliative Care | 1 | 2012 | 213 | 0.080 |
Why?
|
| Pain | 1 | 2012 | 359 | 0.080 |
Why?
|
| Vibration | 1 | 2008 | 7 | 0.080 |
Why?
|
| Sound Spectrography | 1 | 2008 | 14 | 0.080 |
Why?
|
| Risk Factors | 2 | 2016 | 3945 | 0.070 |
Why?
|
| Animals | 1 | 2023 | 13455 | 0.070 |
Why?
|
| Bronchoconstrictor Agents | 1 | 2007 | 1 | 0.070 |
Why?
|
| Methacholine Chloride | 1 | 2007 | 3 | 0.070 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2007 | 114 | 0.060 |
Why?
|
| Young Adult | 1 | 2015 | 4326 | 0.060 |
Why?
|
| Bronchodilator Agents | 1 | 2007 | 77 | 0.060 |
Why?
|
| Arkansas | 2 | 2020 | 2024 | 0.050 |
Why?
|
| Anthropometry | 1 | 2020 | 101 | 0.040 |
Why?
|
| Lost to Follow-Up | 1 | 2019 | 10 | 0.040 |
Why?
|
| Oncology Service, Hospital | 1 | 2019 | 14 | 0.040 |
Why?
|
| Science | 1 | 2017 | 20 | 0.030 |
Why?
|
| Biopsy | 1 | 2020 | 602 | 0.030 |
Why?
|
| Kynurenine | 1 | 2017 | 13 | 0.030 |
Why?
|
| Glutathione Disulfide | 1 | 2017 | 38 | 0.030 |
Why?
|
| Rare Diseases | 1 | 2017 | 47 | 0.030 |
Why?
|
| Myofibroblasts | 1 | 2017 | 50 | 0.030 |
Why?
|
| Biopsy, Needle | 1 | 2017 | 182 | 0.030 |
Why?
|
| Fever | 1 | 2017 | 113 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2019 | 323 | 0.030 |
Why?
|
| Prosthesis Failure | 1 | 2016 | 113 | 0.030 |
Why?
|
| Public Facilities | 1 | 2015 | 4 | 0.030 |
Why?
|
| Talc | 1 | 2015 | 7 | 0.030 |
Why?
|
| Professional Role | 1 | 2016 | 78 | 0.030 |
Why?
|
| Positron-Emission Tomography | 1 | 2017 | 302 | 0.030 |
Why?
|
| Citrulline | 1 | 2016 | 104 | 0.030 |
Why?
|
| Prosthesis Design | 1 | 2016 | 260 | 0.030 |
Why?
|
| Catheters, Indwelling | 1 | 2015 | 58 | 0.030 |
Why?
|
| Spirometry | 1 | 2015 | 33 | 0.030 |
Why?
|
| Drainage | 1 | 2015 | 87 | 0.030 |
Why?
|
| Self Care | 1 | 2016 | 137 | 0.030 |
Why?
|
| Early Diagnosis | 1 | 2015 | 87 | 0.030 |
Why?
|
| Syndrome | 1 | 2015 | 252 | 0.030 |
Why?
|
| Patient Readmission | 1 | 2016 | 246 | 0.030 |
Why?
|
| Amino Acids | 1 | 2016 | 377 | 0.030 |
Why?
|
| Antiphospholipid Syndrome | 1 | 2013 | 8 | 0.030 |
Why?
|
| Patient Discharge | 1 | 2016 | 326 | 0.030 |
Why?
|
| Liver Function Tests | 1 | 2013 | 48 | 0.030 |
Why?
|
| Combined Modality Therapy | 1 | 2015 | 638 | 0.030 |
Why?
|
| Time Factors | 1 | 2019 | 2989 | 0.020 |
Why?
|
| Length of Stay | 1 | 2015 | 672 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2013 | 1044 | 0.020 |
Why?
|
| Cytological Techniques | 1 | 2008 | 13 | 0.020 |
Why?
|
| Inhalation | 1 | 2008 | 6 | 0.020 |
Why?
|
| Exhalation | 1 | 2008 | 21 | 0.020 |
Why?
|